Qualitative and quantitative assessment of endpoints in clinical trials

被引:0
|
作者
Fridrik, M. A. [1 ]
机构
[1] Gen Hosp Linz, Ctr Hematol & Med Oncol, Dept Internal Med 3, Linz, Austria
关键词
Clinical trial; RECIST; endpoints;
D O I
10.1007/s12254-010-0178-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review discusses the complexities of different endpoints in clinical trials. A definition of these endpoints and their value for specific situations will be evaluated.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 50 条
  • [31] A generalized concept of power helped to choose optimal endpoints in clinical trials
    Borm, George F.
    van der Wilt, Gert J.
    Kremer, Jan A. M.
    Zielhuis, Gerhard A.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (04) : 375 - 381
  • [32] Endpoints for randomized controlled clinical trials for COVID-19 treatments
    Dodd, Lori E.
    Follmann, Dean
    Wang, Jing
    Koenig, Franz
    Korn, Lisa L.
    Schoergenhofer, Christian
    Proschan, Michael
    Hunsberger, Sally
    Bonnett, Tyler
    Makowski, Mat
    Belhadi, Drifa
    Wang, Yeming
    Bin Cao
    Mentre, France
    Jaki, Thomas
    CLINICAL TRIALS, 2020, 17 (05) : 472 - 482
  • [33] Endpoints in lung cancer trials: Today's challenges for clinical statistics
    Pilz L.R.
    Manegold C.
    memo - Magazine of European Medical Oncology, 2013, 6 (2) : 92 - 97
  • [34] Defining information fractions in group sequential clinical trials with multiple endpoints
    Xu, Tu
    Qin, Qin
    Wang, Xin
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 10 : 77 - 79
  • [35] Binary surrogate endpoints in clinical trials from the perspective of case definitions
    Hahn, Andreas
    Podbielski, Andreas
    Heimesaat, Markus M.
    Frickmann, Hagen
    Warnke, Philipp
    EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY, 2021, 11 (01): : 18 - 22
  • [36] Evaluation of Endpoints Used in Clinical Trials on Adenomyosis-A Systematic Review
    Rathinam, Kiran Kumar
    Abraham, Justin Jacob
    Karuppaiah, Harish
    Selvaraj, Heema Preethy
    Samal, Sunita
    George, Melvin
    REVIEWS ON RECENT CLINICAL TRIALS, 2023, 18 (02) : 83 - 91
  • [37] Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
    Vagnildhaug, Ola Magne
    Balstad, Trude R.
    Ottestad, Inger
    Bye, Asta
    Greil, Christine
    Arends, Jann
    Baracos, Vickie
    Brown, Leo R.
    Dajani, Olav F.
    Dolan, Ross D.
    Fallon, Marie
    Fraser, Eilidh
    Grzyb, Aleksandra
    Hjermstad, Marianne J.
    Jakobsen, Gunnhild
    Kaasa, Stein
    McDonald, James
    Philips, Iain
    Sayers, Judith
    Simpson, Melanie R.
    Sousa, Mariana S.
    Skipworth, Richard J. E.
    Laird, Barry J. A.
    Solheim, Tora S.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (02) : 513 - 535
  • [38] Photoaversion in inherited retinal diseases: clinical phenotypes, biological basis, and qualitative and quantitative assessment
    Zaman, Serena
    Kane, Thomas
    Katta, Mohamed
    Georgiou, Michalis
    Michaelides, Michel
    OPHTHALMIC GENETICS, 2022, 43 (02) : 143 - 151
  • [39] Assessment of additional endpoints for trials in acute stroke - what, when, where, in who?
    Schellinger, Peter D.
    Bath, Philip M. W.
    Lees, Kennedy R.
    Bornstein, Natan M.
    Uriel, Eitan
    Eisert, Wolfgang
    Leys, Didier
    INTERNATIONAL JOURNAL OF STROKE, 2012, 7 (03) : 227 - 230
  • [40] Assessment of blinding in clinical trials
    Bang, HJ
    Ni, LY
    Davis, CE
    CONTROLLED CLINICAL TRIALS, 2004, 25 (02): : 143 - 156